INSILICO Stock Surges Over 5% in Hong Kong Trading Following Launch of Next-Generation LabClaw System

Stock News05-07

INSILICO (03696) saw its shares rise more than 5% during the trading session. At the time of writing, the stock was up 2.69%, trading at HK$62.95, with a turnover of HK$75.9963 million. On May 7, the company announced the official release of its latest intelligent laboratory operating system, LabClaw. As the pharmaceutical industry's first laboratory automation system designed with a lightweight intelligent agent (Agent-Guard) architecture, LabClaw is specifically tailored for INSILICO's LifeStar2 fully automated laboratory. It aims to drive a paradigm shift in intelligent laboratories from "executing commands" to "autonomous coordination." The system establishes a new tripartite experimental model of "AI thinking, machine execution, and human supervision," deeply integrating INSILICO's proprietary AI target discovery platform PandaOmics, automated laboratory hardware matrix, laboratory information management system (LIMS), and multi-dimensional data analysis pipelines. Through five collaborative AI agents and 28 professional skill modules, LabClaw successfully builds an end-to-end intelligent closed loop for both dry and wet lab processes, spanning from disease target discovery and compound screening to automated experiment execution and data analysis with report generation.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1122984334?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-05-07 11:54","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1122984334","market":"sh","top_or_hot":-1,"title":"INSILICO Stock Surges Over 5% in Hong Kong Trading Following Launch of Next-Generation LabClaw System","media":"Stock News","content":"<p>INSILICO (03696) saw its shares rise more than 5% during the trading session. At the time of writing, the stock was up 2.69%, trading at HK$62.95, with a turnover of HK$75.9963 million. On May 7, the company announced the official release of its latest intelligent laboratory operating system, LabClaw. As the pharmaceutical industry's first laboratory automation system designed with a lightweight intelligent agent (Agent-Guard) architecture, LabClaw is specifically tailored for INSILICO's LifeStar2 fully automated laboratory. It aims to drive a paradigm shift in intelligent laboratories from \"executing commands\" to \"autonomous coordination.\" The system establishes a new tripartite experimental model of \"AI thinking, machine execution, and human supervision,\" deeply integrating INSILICO's proprietary AI target discovery platform PandaOmics, automated laboratory hardware matrix, laboratory information management system (LIMS), and multi-dimensional data analysis pipelines. Through five collaborative AI agents and 28 professional skill modules, LabClaw successfully builds an end-to-end intelligent closed loop for both dry and wet lab processes, spanning from disease target discovery and compound screening to automated experiment execution and data analysis with report generation.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>INSILICO Stock Surges Over 5% in Hong Kong Trading Following Launch of Next-Generation LabClaw System</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nINSILICO Stock Surges Over 5% in Hong Kong Trading Following Launch of Next-Generation LabClaw System\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-05-07 11:54</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>INSILICO (03696) saw its shares rise more than 5% during the trading session. At the time of writing, the stock was up 2.69%, trading at HK$62.95, with a turnover of HK$75.9963 million. On May 7, the company announced the official release of its latest intelligent laboratory operating system, LabClaw. As the pharmaceutical industry's first laboratory automation system designed with a lightweight intelligent agent (Agent-Guard) architecture, LabClaw is specifically tailored for INSILICO's LifeStar2 fully automated laboratory. It aims to drive a paradigm shift in intelligent laboratories from \"executing commands\" to \"autonomous coordination.\" The system establishes a new tripartite experimental model of \"AI thinking, machine execution, and human supervision,\" deeply integrating INSILICO's proprietary AI target discovery platform PandaOmics, automated laboratory hardware matrix, laboratory information management system (LIMS), and multi-dimensional data analysis pipelines. Through five collaborative AI agents and 28 professional skill modules, LabClaw successfully builds an end-to-end intelligent closed loop for both dry and wet lab processes, spanning from disease target discovery and compound screening to automated experiment execution and data analysis with report generation.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03696","symbol_name":"英矽智能","start_time":0,"source_url":"","article_id":"1122984334","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1122984334","pubTimestamp":1778126058,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"INSILICO (03696) saw its shares rise more than 5% during the trading session. At the time of writing, the stock was up 2.69%, trading at HK$62.95, with a turnover of HK$75.9963 million. On May 7, the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03696":"英矽智能","VXUS":"国际股票ETF-Vanguard","BK1141":"生命科学工具和服务","BK4588":"碎股","BK4585":"ETF&股票定投概念"},"translate_title":"推出下一代LabClaw系统后，INSILICO股价在香港交易中飙升超过5%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"VXUS":1,"03696":1},"content_text":"INSILICO (03696) saw its shares rise more than 5% during the trading session. At the time of writing, the stock was up 2.69%, trading at HK$62.95, with a turnover of HK$75.9963 million. On May 7, the company announced the official release of its latest intelligent laboratory operating system, LabClaw. As the pharmaceutical industry's first laboratory automation system designed with a lightweight intelligent agent (Agent-Guard) architecture, LabClaw is specifically tailored for INSILICO's LifeStar2 fully automated laboratory. It aims to drive a paradigm shift in intelligent laboratories from \"executing commands\" to \"autonomous coordination.\" The system establishes a new tripartite experimental model of \"AI thinking, machine execution, and human supervision,\" deeply integrating INSILICO's proprietary AI target discovery platform PandaOmics, automated laboratory hardware matrix, laboratory information management system (LIMS), and multi-dimensional data analysis pipelines. Through five collaborative AI agents and 28 professional skill modules, LabClaw successfully builds an end-to-end intelligent closed loop for both dry and wet lab processes, spanning from disease target discovery and compound screening to automated experiment execution and data analysis with report generation.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1122984334","isCrawlerRequest":true}